Akitake Mukasa Selected Research

PD 128042

6/2022

Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akitake Mukasa Research Topics

Disease

31	Neoplasms (Cancer) 07/2022 - 06/2002
25	Glioma (Gliomas) 04/2022 - 01/2002
21	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2004
7	Brain Neoplasms (Brain Tumor) 03/2022 - 12/2015
6	Germinoma 01/2022 - 07/2011
6	Oligodendroglioma 09/2021 - 06/2002
4	Lymphoma (Lymphomas) 06/2022 - 01/2018
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 08/2015
4	Astrocytoma (Pilocytic Astrocytoma) 09/2021 - 01/2004
3	Aneurysm (Aneurysms) 04/2021 - 01/2019
3	Pituitary Neoplasms (Pituitary Adenoma) 09/2019 - 11/2018
2	Stroke (Strokes) 01/2022 - 06/2019
2	Infarction (Infarctions) 01/2022 - 04/2021
2	Carcinogenesis 09/2021 - 12/2017
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 11/2012
2	Intracranial Vasospasm 01/2020 - 06/2019
2	Breast Neoplasms (Breast Cancer) 07/2019 - 07/2018
2	Cognitive Dysfunction 01/2019 - 06/2018
2	Necrosis 12/2018 - 12/2016
2	Moyamoya Disease (Moya-Moya Disease) 10/2013 - 12/2012
1	Rectal Neoplasms (Rectal Cancer) 03/2022
1	Adenocarcinoma 03/2022
1	Spinal Cord Diseases 02/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Temporal Lobe Epilepsy 01/2022
1	Blood Vessel Dissection 04/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Depressed Skull Fracture 07/2020
1	Microsatellite Instability 05/2020
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2012
7	Biological ProductsIBA 09/2021 - 06/2002
5	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2004
5	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 01/2014
5	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2002
4	EnzymesIBA 01/2021 - 11/2016
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2017 - 03/2012
3	Phosphotransferases (Kinase)IBA 11/2020 - 02/2010
3	epidermal growth factor receptor VIIIIBA 01/2018 - 07/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2010
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2016
2	Histones (Histone)IBA 11/2020 - 01/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2020 - 07/2019
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2018
2	Growth Hormone (Somatotropin)IBA 09/2019 - 01/2019
2	eribulin FDA Link 07/2019 - 07/2018
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2017
2	ChromatinIBA 12/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 08/2015 - 01/2014
2	Doxycycline (Periostat)FDA LinkGeneric 07/2011 - 02/2010
2	OligonucleotidesIBA 02/2004 - 06/2002
1	PD 128042IBA 06/2022
1	CholesterolIBA 06/2022
1	LipidsIBA 06/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 04/2022
1	SteroidsIBA 02/2022
1	InterleukinsIBA 01/2022
1	N(6)-allyl-N(6)-cyclohexyladenosineIBA 01/2022
1	AntigensIBA 01/2022
1	Fibroblast Growth Factor 1 (FGF-1)IBA 09/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Aminolevulinic Acid (Levulan)FDA Link 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	DipeptidesIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	RhodaminesIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 11/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2020
1	TitaniumIBA 07/2020
1	Ribosomal Protein S6IBA 06/2020
1	MethyltransferasesIBA 05/2020
1	Interferon-betaIBA 05/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	CatecholaminesIBA 01/2020
1	folylpolyglutamate synthetaseIBA 01/2020
1	Vorinostat FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	HydrolasesIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 12/2019

Therapy/Procedure

15	Therapeutics 07/2022 - 01/2002
10	Radiotherapy 03/2022 - 07/2011
10	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
2	Craniotomy 03/2022 - 07/2015
2	Cerebral Revascularization 01/2022 - 07/2019
2	Stents 06/2019 - 12/2015
1	Molecular Targeted Therapy 01/2022
1	Precision Medicine 01/2022
1	Conservative Treatment 04/2021
1	Ligation 04/2021
1	Denervation 01/2020